» Articles » PMID: 36531735

Machine Learning Models in Heart Failure with Mildly Reduced Ejection Fraction Patients

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Heart failure with mildly reduced ejection fraction (HFmrEF) has been recently recognized as a unique phenotype of heart failure (HF) in current practical guideline. However, risk stratification models for mortality and HF re-hospitalization are still lacking. This study aimed to develop and validate a novel machine learning (ML)-derived model to predict the risk of mortality and re-hospitalization for HFmrEF patients.

Methods: We assessed the risks of mortality and HF re-hospitalization in HFmrEF (45-49%) patients enrolled in the TOPCAT trial. Eight ML-based models were constructed, including 72 candidate variables. The Harrell concordance index (C-index) and DeLong test were used to assess discrimination and the improvement in discrimination between models, respectively. Calibration of the HF risk prediction model was plotted to obtain bias-corrected estimates of predicted versus observed values.

Results: Least absolute shrinkage and selection operator (LASSO) Cox regression was the best-performing model for 1- and 6-year mortality, with a highest C-indices at 0.83 (95% CI: 0.68-0.94) over a maximum of 6 years of follow-up and 0.77 (95% CI: 0.64-0.89) for the 1-year follow-up. The random forest (RF) showed the best discrimination for HF re-hospitalization, scoring 0.80 (95% CI: 0.66-0.94) and 0.85 (95% CI: 0.71-0.99) at the 6- and 1-year follow-ups, respectively. For risk assessment analysis, Kansas City Cardiomyopathy Questionnaire (KCCQ) subscale scores were the most important predictor of readmission outcome in the HFmrEF patients.

Conclusion: ML-based models outperformed traditional models at predicting mortality and re-hospitalization in patients with HFmrEF. The results of the risk assessment showed that KCCQ score should be paid increasing attention to in the management of HFmrEF patients.

Citing Articles

Predictive Analytics in Heart Failure Risk, Readmission, and Mortality Prediction: A Review.

Hidayaturrohman Q, Hanada E Cureus. 2024; 16(11):e73876.

PMID: 39697926 PMC: 11652958. DOI: 10.7759/cureus.73876.


Machine learning models for predicting risks of MACEs for myocardial infarction patients with different VEGFR2 genotypes.

Kirdeev A, Burkin K, Vorobev A, Zbirovskaya E, Lifshits G, Nikolaev K Front Med (Lausanne). 2024; 11:1452239.

PMID: 39301488 PMC: 11410707. DOI: 10.3389/fmed.2024.1452239.


Web-Based Dynamic Nomogram for Predicting Risk of Mortality in Heart Failure with Mildly Reduced Ejection Fraction.

Guo W, Tian J, Wang Y, Zhang Y, Yan J, Du Y Risk Manag Healthc Policy. 2024; 17:1959-1972.

PMID: 39156077 PMC: 11330247. DOI: 10.2147/RMHP.S474862.


Machine learning in heart failure diagnosis, prediction, and prognosis: review.

Saqib M, Perswani P, Muneem A, Mumtaz H, Neha F, Ali S Ann Med Surg (Lond). 2024; 86(6):3615-3623.

PMID: 38846887 PMC: 11152866. DOI: 10.1097/MS9.0000000000002138.

References
1.
Coglianese E, Qureshi M, Vasan R, Wang T, Moore L . Usefulness of the blood hematocrit level to predict development of heart failure in a community. Am J Cardiol. 2011; 109(2):241-5. PMC: 3663594. DOI: 10.1016/j.amjcard.2011.08.037. View

2.
Pokharel Y, Khariton Y, Tang Y, Nassif M, Chan P, Arnold S . Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Cardiol. 2017; 2(12):1315-1321. PMC: 5814994. DOI: 10.1001/jamacardio.2017.3983. View

3.
Zafrir B, Lund L, Laroche C, Ruschitzka F, Crespo-Leiro M, Coats A . Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J. 2018; 39(48):4277-4284. DOI: 10.1093/eurheartj/ehy626. View

4.
Becher P, Schrage B, Ferrannini G, Benson L, Butler J, Carrero J . Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry. Eur J Heart Fail. 2021; 23(6):1012-1022. DOI: 10.1002/ejhf.2131. View

5.
Stekhoven D, Buhlmann P . MissForest--non-parametric missing value imputation for mixed-type data. Bioinformatics. 2011; 28(1):112-8. DOI: 10.1093/bioinformatics/btr597. View